Wockhardt gets Indian regulator's nod for 2 new antibiotics; stock up 6%
Highlight
January 16, 2020
0 Comments
Indian drug regulator, DCGI has approved Wockhardt’s two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and ski...
Read More